BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24975300)

  • 1. Hepatitis B infection in Eastern Mediterranean Region: challenges and the way forward.
    Qureshi H
    East Mediterr Health J; 2013 Jul; 19(7):585-6. PubMed ID: 24975300
    [No Abstract]   [Full Text] [Related]  

  • 2. Priorities and challenges for hepatitis B control in the Philippines and the importance of a vaccine dose at birth.
    Ruff TA; Bravo L; Gatchalian SR; Bock HL
    Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):972-90. PubMed ID: 19842381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal hepatitis B vaccination.
    Kretzschmar M; de Wit A
    Lancet Infect Dis; 2008 Feb; 8(2):85-7; author reply 90. PubMed ID: 18222156
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis B control among children in the Eastern Mediterranean Region of the World Health Organization.
    Allison RD; Teleb N; Al Awaidy S; Ashmony H; Alexander JP; Patel MK
    Vaccine; 2016 May; 34(21):2403-2409. PubMed ID: 27043863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiology and prevention of hepatitis A and B in developing countries].
    Zaratti L; Meleleo C; Serino L; Bagnato B; Marino MG; Morciano L; Sorbara D; Franco E
    Ig Sanita Pubbl; 2011; 67(1):119-28. PubMed ID: 21468158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal neonatal immunization for Hepatitis B.
    Thies N
    J Paediatr Child Health; 2002 Apr; 38(2):211; author reply 211-2. PubMed ID: 12031012
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [National hepatitis B vaccination closer to implementation, but not soon enough: recommendations from the Dutch Health Council].
    Gunning-Schepers LJ; Houweling H
    Ned Tijdschr Geneeskd; 2001 Aug; 145(32):1572-3. PubMed ID: 11525094
    [No Abstract]   [Full Text] [Related]  

  • 9. [Coverage of vaccination against hepatitis B in Poland in 2004].
    Magdzik W; Czarkowski MP
    Przegl Epidemiol; 2006; 60(2):185-92. PubMed ID: 16964668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B: the global problem, its prevention and future, and role of IMA.
    Roy S; Chakrabortti SC
    J Indian Med Assoc; 2000 Jul; 98(7):366. PubMed ID: 11143853
    [No Abstract]   [Full Text] [Related]  

  • 11. Age at presentation for infant immunization in Nigeria: implications for hepatitis B immunization.
    Sadoh AE; Eregie CO
    Public Health; 2008 Dec; 122(12):1318-20. PubMed ID: 18706664
    [No Abstract]   [Full Text] [Related]  

  • 12. Denmark decides not to introduce hepatitis B into the childhood vaccination programme.
    Cowan SA
    Euro Surveill; 2005 Nov; 10(11):E051103.3. PubMed ID: 16794274
    [No Abstract]   [Full Text] [Related]  

  • 13. Many ways to contract hepatitis B, one key way to prevent it.
    Grabenstein JD
    J Am Pharm Assoc (Wash); 1998; 38(5):636. PubMed ID: 9782700
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B leading to hepatocellular carcinoma: calculating the risk.
    Puliyel JM; Taneja V; Jindal K; Thomas N
    Indian J Gastroenterol; 2001; 20(6):251-2. PubMed ID: 11817790
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vaccination against hepatitis B and epidemiological situation of this disease in European countries in the years 1990-2001].
    Magdzik W
    Przegl Epidemiol; 2006; 60(2):179-84. PubMed ID: 16964667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the efficacy of the national immunization programme for hepatitis B.
    Rubin L; Hefer E; Dubnov Y; Warman S; Rishpon S
    Public Health; 2007 Jul; 121(7):529-33. PubMed ID: 17320126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why should Australia adopt universal infant hepatitis B vaccination?
    Thompson SC; Oman K
    Aust N Z J Public Health; 1996 Aug; 20(4):436-9. PubMed ID: 8908772
    [No Abstract]   [Full Text] [Related]  

  • 18. The risk of acquiring hepatitis A and B among travelers in selected Eastern and Southern Europe and non-European Mediterranean countries: review and consensus statement on hepatitis A and B vaccination.
    Nothdurft HD; Dahlgren AL; Gallagher EA; Kollaritsch H; Overbosch D; Rummukainen ML; Rendi-Wagner P; Steffen R; Van Damme P;
    J Travel Med; 2007; 14(3):181-7. PubMed ID: 17437475
    [No Abstract]   [Full Text] [Related]  

  • 19. Denmark scales up hepatitis B screening and vaccination for risk groups.
    Cowan SA
    Euro Surveill; 2005 Nov; 10(11):E051103.4. PubMed ID: 16794275
    [No Abstract]   [Full Text] [Related]  

  • 20. [Updated STIKO vaccination recommendations published].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2013 Sep; 36(9):317. PubMed ID: 24069644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.